View Item 

Show simple item record

A Multicenter Randomized Clinical Trial Evaluating Interleukin-2 Activated Hematopoietic Stem Cell Transplantation and Post-transplant IL-2 for High Risk Breast Cancer Patients
dc.contributor.authorHerscowitz, Herberten_US
dc.contributor.authorIsaacs, Claudineen_US
dc.contributor.authorSlack, Rebeccaen_US
dc.contributor.authorGehan, Edmunden_US
dc.contributor.authorBallen, Karenen_US
dc.contributor.authorBoccia, Ralphen_US
dc.contributor.authorAreman, Ellenen_US
dc.contributor.authorKramer, Ruthieen_US
dc.contributor.authorHayes, Daniel F.en_US
dc.contributor.authorLippman, Marc E.en_US
dc.date.accessioned2006-09-11T14:28:36Z
dc.date.available2006-09-11T14:28:36Z
dc.date.issued2005-09en_US
dc.identifier.citationIsaacs, Claudine; Slack, Rebecca; Gehan, Edmund; Ballen, Karen; Boccia, Ralph; Areman, Ellen; Kramer, Ruthie; Hayes, Daniel F.; Herscowitz, Herbert; Lippman, Marc; (2005). "A Multicenter Randomized Clinical Trial Evaluating Interleukin-2 Activated Hematopoietic Stem Cell Transplantation and Post-transplant IL-2 for High Risk Breast Cancer Patients." Breast Cancer Research and Treatment 93(2): 125-134. <http://hdl.handle.net/2027.42/44232>en_US
dc.identifier.issn0167-6806en_US
dc.identifier.issn1573-7217en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/44232
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=16187232&dopt=citationen_US
dc.description.abstractThis Phase III randomized multicenter trial compared progression-free (PFS) and overall survival (OS) for autologous peripheral blood stem cell (aPBSC) transplantation with or without immunotherapy in high-risk breast cancer patients.en_US
dc.format.extent297384 bytes
dc.format.extent3115 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherKluwer Academic Publishers; Springeren_US
dc.subject.otherStem Cell Transplantationen_US
dc.subject.otherOncologyen_US
dc.subject.otherMedicine & Public Healthen_US
dc.subject.otherBreast Canceren_US
dc.subject.otherImmunotherapyen_US
dc.subject.otherInterleukin-2en_US
dc.titleA Multicenter Randomized Clinical Trial Evaluating Interleukin-2 Activated Hematopoietic Stem Cell Transplantation and Post-transplant IL-2 for High Risk Breast Cancer Patientsen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelOncology and Hematologyen_US
dc.subject.hlbsecondlevelNeurosciencesen_US
dc.subject.hlbsecondlevelObstetrics and Gynecologyen_US
dc.subject.hlbsecondlevelOphthalmologyen_US
dc.subject.hlbsecondlevelOtolaryngologyen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbsecondlevelPublic Healthen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDivision of Hematology and Oncology, Lombardi Comprehensive Cancer Center, Washington, DC, 20057, USA; Department of Internal Medicine, University of Michigan Health and Hospital System, Ann Arbor, MI, USAen_US
dc.contributor.affiliationumDivision of Hematology and Oncology, Lombardi Comprehensive Cancer Center, Washington, DC, 20057, USA; Department of Internal Medicine, University of Michigan Health and Hospital System, Ann Arbor, MI, USAen_US
dc.contributor.affiliationotherDivision of Biostatistics and Bioinformatics, Department of Oncology, Lombardi Comprehensive Cancer Center, Washington, DC, USAen_US
dc.contributor.affiliationotherStem Cell Transplant Program, Holy Cross Hospital, Silver Spring, Maryland, USAen_US
dc.contributor.affiliationotherClinical Research Management Office, Lombardi Comprehensive Cancer Center, Washington, DC, USAen_US
dc.contributor.affiliationotherDivision of Hematology and Oncology, Lombardi Comprehensive Cancer Center, Washington, DC, 20057, USA; Breast Cancer Program, Lombardi Comprehensive Cancer Center, 3800 Reservoir Rd, NW, Washington, DC, 20057, USAen_US
dc.contributor.affiliationotherDivision of Biostatistics and Bioinformatics, Department of Oncology, Lombardi Comprehensive Cancer Center, Washington, DC, USAen_US
dc.contributor.affiliationotherBone Marrow Transplant Program, University of Massachusetts Memorial Medical Center, Lake Avenue, Worcester, Massachusetts, USAen_US
dc.contributor.affiliationotherDivision of Hematology and Oncology, Lombardi Comprehensive Cancer Center, Washington, DC, 20057, USAen_US
dc.contributor.affiliationotherMicrobiology and Immunology, Georgetown University Medical Center, Washington, DC, USAen_US
dc.contributor.affiliationumcampusAnn Arboren_US
dc.identifier.pmid16187232en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/44232/1/10549_2005_Article_4445.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1007/s10549-005-4445-yen_US
dc.identifier.sourceBreast Cancer Research and Treatmenten_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
10549_2005_Article_4445.pdf
Size:
290.4KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.